»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ h(WrL
*JggU
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 LU!dN "[k
rG,5[/l
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© P[s8JDqu
1.Antigen presenting cell£¨APC£© hig2
2.Activation induced cell death£¨AICD£© GfM;saTz{
3.Chemokine (sVi\R
4.Major histocompatibility complex£¨MHC£© y:v, j42%
5.immunotolerance 9 \^|6k,
j xYc2
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© R|i/lEq
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ n3J53| %v
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà Z7 E
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ re> rr4@
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ Y@PI {;!
5.±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌصã qJ0fQI\
eh"3NRrN
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© 42]pYm(jk3
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ zt^48~ry
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ .*elggM
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ ZE%YXG
g2unV[()_
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ |HZTN"
:d ~|jS
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 y\&>ZyOY
PTj&3`v
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ aF7nvu*N
1.Antigenic determinant (%`QhH
2.IgSF s: 3z'4oX
3.MBL;¾¶ Y@ZaJ@%9@
4.chemokine n-DVT;y
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ 3"rzb]=
R
6.TCR-CD3¸´ºÏÎï Y"KE7>Jf
7.FADD£¨Fas-associated protein with death domain£© [
d* ~@P
8.AIDS t=xOQ8
9.Tumor rejection antigen f3UXCp
10.AICD
]
Eh}L
g(#f:"
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ e)?Fi
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© !
Kv@\4
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ )Z %T27r,^
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ HOBP`lf
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì w4fW<ISg
not YeY7wR
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ h`3eu;5)
8|$3OVS
r#6_]ep}<'
רҵ¿Î ÃâÒßѧ &hk-1y9QS
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê aj}(E+
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell z.}[m,oTF
5. Fc¦Å receptor 6. Cytokine +Y+Y6Ac[}
¶þ¡¢ ÎÊ´ðÌâ %E_b'[8
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØɱÉË°Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 Ve
4u +0
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ _@R0x#p5M
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁÜ°ÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ 07hF2[i
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâЩÌصãµÄÉúÎïѧÒâÒ壿
=V^.}WtO
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦Óᣠ<G*nDFWf
~gu3g^<0v
`ImE% r!
Dnc<sd;
\8uIER5)
BAO| )~1Pd
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ l|hUw
HfLLlH<L`&
5?Wto4j
רҵ¿Î ÃâÒßѧ <?D\+khlq
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê 1 tR_8lC
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen !|<=ZF2
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin !*`-iQo&
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test ]
7 _`]7p
9. Hybridoma technic 10.Mitogen Oq3A#6~
11.Dentritic cell 12.Immunoproliferation boo
}u
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ # M!!CX*k
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨Äļ¸¸öÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ !!o8N<NU
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦ÓᣠA0%}v*
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ ,<:!NF9
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ 1xc~`~
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ t
5[[JD
1V
@JW@-9/
yAN=2fZm
t^ZV|s 1
#Mg]GeDJ{
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ M4WiT<|]R
iZZ (4
H}LS??P
רҵ¿Î ÃâÒßѧ IuZ) [*W
Ò»¡¢ Ãû´Ê½âÊÍ .IJ_jt-^d
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï S1U@UC
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà XW?b\!@ $
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ "6a8s;
¶þ¡¢ ÎÊ´ðÌâ xF8}:z0
1¡¢ TÁÜ°Íϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ 0<TD/1wN
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁÜ°Íϸ°ûºÍЧӦÎïÖÊ¡£ &P,^.'
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆ乲ͬÌص㼰ÓëÁÙ´²µÄ¹Øϵ¡£ *GUAO){'
4¡¢ ºÎνÁÜ°Íϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ Uje|`<X
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØϵͳ£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ v2,%K`pAU
0qrq
g]
_uc\ D
R
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 0R0{t=VJZ
}Yv\0\~'W|
kcDyuM`
רҵ¿Î ÃâÒßѧ % },Pe
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê -VZR
ujl
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR 5b/ojr7
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA -{
u*qtp
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM r ]>\~&?^F
¶þ¡¢ ÎÊ´ðÌâ Q o =
Kqv
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌص㡣 {7MjP+\
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ 1p'Le!
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖƵÄÒìͬµã¡£ ",>H(wJ8
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆ书ÄÜ¡£ EVQ0l@K
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ _8G>&K3T<
!jqWwi
Gs2p5nL<
, %YBG1E[y
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 8e0."o.6
@DC)]C2
[@fz1{*
רҵ¿Î ÃâÒßѧ zhB ">j8j
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê
tZ2e!<C
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule 0i
Ea[G3
5. Autogous mixed lymphoyte reaction 8dK0o>|}
¶þ¡¢ ÎÊ´ðÌâ nW?R"@Zm
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ =8=!Yc(>
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ `:M^8SYrL
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠ@6o]chJo
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹Øϵ£¿ #pdUJ2)yM
>NV=LOO
>u J/TQU
FbACTeB
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ j;K#]
VSOz.g>
o/^
;@5\
רҵ¿Î ÃâÒßѧ NBl
__q
EP7AP4
ELa ja87
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê /&ygi H{^
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance y,+[$u7h
5. Delayed type hypersensitivity &~5=K
¶þ¡¢ ÎÊ´ðÌâ f3WS
a&eF
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ %c^ m\E
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ EEf ]u7
3. ¼òÊöHLAÓëҽѧµÄ¹Øϵ¡£ :XT?jdg
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ"PpjoM
~
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷Óᣠ=?0QqCjK)
dYOF2si~%
#\If]w*j
aW5~Be$
_
:Eh'(
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ #w3ru6*W
w! q&
XKLF8~y8A
רҵ¿Î ÃâÒßѧ I>w^2(y
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê ^>r^3C)_-
1. hypersensitivity 2. cluster of differentiation L{ ^4DznI
3. adhesion molecules 4. supper antigen 5. split tolerance VfSGCe
¶þ¡¢ ÎÊ´ðÌâ +?N}Y {Y&
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£
fCEz-TMW
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ Z6=~1'<X
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ P%o44|[][
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ j|'R$|
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ Q(\ wx
|"}4*V_ *
dm^H5D/A
Xm[Czd]%
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ .S vyj
רҵ¿Î ÃâÒßѧ _ 5\AS+[x
Ò»¡¢ Ãû´Ê½âÊÍ >C2HC6O
3
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å 29O]S8
5. GVHR ic~Z_?p
¶þ¡¢ ÎÊ´ðÌâ u:4["ViC
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óᣠ(
Yi=v'd
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌصãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ _bQL[eXd
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌص㡣 iB{xvyR
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ 91;HiILgT
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ ?N#[<kd
b{HhS6<K?
/oDpgOn
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ {"4<To]z
$n*%v85
"z/V%ZK~f
רҵ¿Î ÃâÒßѧ Sf5]=F-w
Ò»¡¢Ãû´Ê½âÊÍ
pDhY%w#
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å nhT;b,G.Z
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ : ~'Z(-a
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ WJcVQMs
11. »ìºÏÁÜ°Íϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ 4@))OD^ x
Èý¡¢ ÎÊ´ðÌâ q4k`)?k9
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ {|p"; uJ
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ =WjJN Q
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà %ph"PR/t?
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ aL 8Gnqf2
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ
RK;;b~
OgTSx
:B+Rg cqi
DOT=U
_
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ _2; ^v`[
|I/,F;'
l-MxLcz
רҵ¿Î ÃâÒßѧ hafECs
Ò»¡¢Ãû´Ê½âÊÍ y-<$bA[K~
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó 1h{>[ 'L
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁÜ°Íϸ°ûµÄ±íÃæ±êÖ¾ G#'Q~N
Èý¡¢ ÎÊ´ðÌâ V 1*Ad
1. ¼òÊöTÁÜ°Íϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ QjqBO+
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ yz8-&4YRNd
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ htV#5SUx&
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ Jxn3$
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ zw
,-.fmM#
b h*^{
xl3zy~;
M
au,jAk
v7L"`
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ _/ct=
Ò»¡¢Ãû´Ê½âÊÍ \WiqN*ZF
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï 2+,5p
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó J"5jy$30'$
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ u0s'6=
¶þ¡¢ ÎÊ´ðÌâ 6NzBpur 2H
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ eN2dy-0
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ {=s:P|ah
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ c%ZeX%p
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ TeKC} NW
|xp$OL"a
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ l<W*/}3
Ò»¡¢ Ãû´Ê½âÊÍ Wx}M1&d/J
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ |MR%{ZC^i
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ E2Us#a
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© Cy<T Vk8
10¡¢ ÒõÐÔÑ¡Ôñ ~B<97x(X
¶þ¡¢ ÎÊ´ðÌâ n"mJEkHE
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 u\M4`p!g=
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ I<c@uXXV;!
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 4pLQ"&>}80
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ ,wEM
Jh
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. anK[P'Y
+d@v
AxP
sk~ za
TG4\%S$w
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ 'uPxEu4 >4
v$[ @]`
Km[]^;6
רҵ¿Î ÃâÒßѧ >BJ2v=RA
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ ;>inT7?3|
1. Cytokines 2. adhesion molecules 3. graft versus host reaction h~,x7]w6
4. immunologic tolerance 5. Opsonization =ZCH1J5"
Èý¡¢ ÎÊ´ðÌâ se~ *<5
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷Óᣠny278tr Q7
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ [Xs}FJ
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ 7YMxr3F
4. ÃâÒßϵͳɱÉË°Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ 0\V\qAk
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ 3Qqnw{*
@:S$|D~
\%w7D6dEZ
$.ymby
z2rQ$O-#
r0~ 7v1rG
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ B=Xnv*e
k\4
g|Lya
^?H\*N
4
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ VaD
:
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ ZrmnQ
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê ZkJY.H-F
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ j zxf"X-
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û hXV4$Dai
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö Iu=pk@*O
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð D]t~S1ycG7
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖƱ¸ÔÀí¡£ \_iH4<
#>
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ :d!i[W*
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃ濹ԺͱíÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© ;cS~d(%
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ o`<h=+a\
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ f)&`mqeE
"wc`fg"3
&
* V0(
kw*Cr/'*
ZaEBdBv
Z'*G'/*
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ [# H8=
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ : L6-{9$
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ L<[,7V
h=p-0 Mx .
Ò»¡¢ Ãû´Ê½âÊÍ BDB zc5Q(
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß l(0&6ENyj
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò h0y\,iWXb
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô PBPJ/puW
¶þ¡¢ÎÊ´ðÌâ nU">> 1!U
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ +v `^_
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì W~W?<%@
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì z9uEOX&2\
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£ n
WO~v{h3J
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ RY'\mt"W2
%n V@'3EI